Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents

European Journal of Medicinal Chemistry
2011.0

Abstract

A series of new 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydro quinazolinone hybrids with different linker architectures have been designed and synthesized. These compounds have been evaluated for their anticancer activity. One of the compounds 4c amongst this series has shown promising anticancer activity. Further some detailed biological assays relating to the cell cycle aspects and tubulin depolymerization activity have been examined with a view to understand the mechanism of action of this conjugate.

Knowledge Graph

Similar Paper

Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents
European Journal of Medicinal Chemistry 2011.0
Synthesis of tetrazole–isoxazoline hybrids as a new class of tubulin polymerization inhibitors
MedChemComm 2012.0
Synthesis and structure–activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization
European Journal of Medicinal Chemistry 2015.0
Synthesis, single crystal and antitumor activities of benzimidazole–quinazoline hybrids
Bioorganic & Medicinal Chemistry Letters 2013.0
Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates
Bioorganic & Medicinal Chemistry 2011.0
Synthesis of new conjugated coumarin–benzimidazole hybrids and their anticancer activity
Bioorganic & Medicinal Chemistry Letters 2013.0
Design, Synthesis and Biological Evaluation of the Novel Antitumor Agent 2-benzyl-3, 4-dihydroisoquinolin-1(2H)-one and Its Derivatives
Lecture Notes in Electrical Engineering 2014.0
Isoindolo[2,1-a]quinoxaline Derivatives, Novel Potent Antitumor Agents with Dual Inhibition of Tubulin Polymerization and Topoisomerase I
Journal of Medicinal Chemistry 2008.0
Design, synthesis and biological evaluation of (E)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents
Bioorganic & Medicinal Chemistry Letters 2014.0
6-Alkylamino- and 2,3-Dihydro-3‘-methoxy-2-phenyl-4-quinazolinones and Related Compounds:  Their Synthesis, Cytotoxicity, and Inhibition of Tubulin Polymerization
Journal of Medicinal Chemistry 2000.0